Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
BSPRY - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PARVB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
COBL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM169A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CENPV - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LARP6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF74 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MXRA7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
BNIP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TADA2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPINT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLIT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OVOL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OSBPL8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM106B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PTPRN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SYNM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LTBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on